7 Results for "

LMWH

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "LMWH" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-109509
CAS No.: 679809-58-6
Synonyms: PK 10169; Enoxaparin sodium
Enoxaparin (PK 10169), a low-molecular-weight heparin (LMWH) derivative. Enoxaparin exerts anticoagulant activity through antithrombin III, an endogenous inhibitor of factor Xa and thrombin IIa. Enoxaparin protect the rat hippocampus against TBI (traumatic brain injury) via antioxidant and anti-inflammatory properties. Enoxaparin can be used for the research of deep vein thrombosis (DVT), pulmonary embolism, TBI and COVID-19 .
loading...
    loading...
Cat. No.: HY-P2839
CAS No.: 9025-39-2
Synonyms: Heparinase I
Target:  

Endogenous Metabolite

Research Areas:  

Metabolic Disease

Heparinase (Heparinase I) degrades heparin to oligosaccharide or unsaturated disaccharide. Heparinase can be used in the preparation of low molecular weight heparin (LMWH) .
loading...
    loading...
Cat. No.: HY-18660
CAS No.: 1438492-26-2
Synonyms: PER977
Target:  

Factor Xa Thrombin

Research Areas:  

Cardiovascular Disease

Ciraparantag (PER977) is a thrombin and factor Xa inhibitor. Ciraparantag is a broad-spectrum reversal agent for anticoagulants, including low-molecular-weight heparin, unfractionated heparin, and certain direct oral anticoagulants. It is reported to antagonize the effects of all coagulants except VKAs and agratroban .
loading...
    loading...
Cat. No.: HY-P5107A
Synonyms: LMWP acetate; TDSP5 acetate
Target:  

VEGFR

Research Areas:  

Cancer

Low molecular weight protamine acetate (LMWP acetate;TDSP5 acetate) is a truncated arginine-rich protamine peptide, which also acts as an antidote for heparin/low molecular weight heparin and a cell-penetrating delivery vector. Low molecular weight protamine acetate neutralizes heparin-induced anticoagulant activities, including aPTT, anti-Xa and anti-IIa activities. Low molecular weight protamine acetate translocates across mammalian cell membranes, delivers conjugated impermeable molecules through tumor tissues, enhances the skin permeability of conjugated epidermal growth factor, and accelerates wound healing when conjugated with epidermal growth factor. Low molecular weight protamine acetate retains the in vitro cell proliferation activity of conjugated EGF, and also enables site-specific conjugation with peptides or proteins via genetic recombination. Low molecular weight protamine acetate can be used in studies related to colon cancer, skin wounds and diabetic skin wounds .
loading...
    loading...
Cat. No.: HY-157930
Research Areas:  

Cardiovascular Disease

TP-2, a caltrop-like multicationic small molecule, is an antidote that can completely neutralize both unfractionated heparin (UFH) and low-molecular-weight heparins (LMWHs). TP-2 is not only superior to protamine, has higher neutralization activity, but is also biocompatible .
loading...
    loading...
Cat. No.: HY-105240
CAS No.: 872454-31-4
Synonyms: PMX-60056
Target:  

Factor Xa

Research Areas:  

Cardiovascular Disease

Delparantag (PMX-60056) is a salicylamide derivative and an effective unfractionated heparin (UFH) and low molecular weight heparin (LMWH) reversing agent. Delparantag shows ability to neutralize the anticoagulation and bleeding effects of UFH and LMWH .
loading...
    loading...
Cat. No.: HY-18660A
CAS No.: 1438492-27-3
Synonyms: PER977 TFA
Target:  

Factor Xa Thrombin

Research Areas:  

Cardiovascular Disease

Ciraparantag (PER977) TFA is a thrombin and factor Xa inhibitor. Ciraparantag TFA is a broad-spectrum reversal agent for anticoagulants, including low-molecular-weight heparin, unfractionated heparin, and certain direct oral anticoagulants. It is reported to antagonize the effects of all coagulants except VKAs and agratroban .
loading...
    loading...